Douglas D. Lazarus

27 papers receiving 2.7k citations

Douglas D. Lazarus's Hit Papers

Proteasome inhibitors: a novel class of potent and effective antitumor agents. 1999 · 1.3k citations
1.3k0+9+18Years since publication4008001.2k

Peers

Douglas D. Lazarus
Comparison fields: 5 of 118
  • Hematology 394
  • Oncology 729
  • Cancer Research 381
  • Molecular Biology 1.5k
  • Immunology 399
Replace Brigitte Bauvois with:
Brigitte Bauvois France
Masaki Hiramoto Japan
Maria Teresa Scupoli Italy
Lidija Klampfer United States
Jiin‐Tsuey Cheng Taiwan
Siegfried Stengelin Germany
Arántzazu Alfranca Spain
Frédéric Lopez France
Suk Ran Yoon South Korea
C J Edgell United States
Douglas D. Lazarus relative to Brigitte Bauvois France Brigitte Bauvois's profile →
Citations per field
00.5×1.5×1.8×
Brigitte Bauvois · 1×
Citations per year

Countries citing papers authored by Douglas D. Lazarus

Since Specialization
Citations

This map shows the geographic impact of Douglas D. Lazarus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas D. Lazarus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas D. Lazarus more than expected).

Fields of papers citing papers by Douglas D. Lazarus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas D. Lazarus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas D. Lazarus. The network helps show where Douglas D. Lazarus may publish in the future.

Co-authors

The 25 scholars most cited alongside Douglas D. Lazarus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Douglas D. Lazarus Line = papers co-authored together Douglas D. Lazarus links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Proteasome inhibitors: a novel class of potent and effective antitumor agents.
Hit paper breakdown →
19991258
2 1998259
3 1995244
4 1993134
5 2013124
6 200495
7 201483
8 199780
9 201660
10 201559
11
Insulin-like growth factor-1 activity is inhibited by interleukin-1 alpha, tumor necrosis factor-alpha, and interleukin-6.
199358
12
Influence of hypercortisolemia on the acute-phase protein response to endotoxin in humans.
199250
13 199944
14 199941
15 198736
16 199236
17 199530
18 198826
19 201623
20 199622

About Douglas D. Lazarus

Douglas D. Lazarus is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research, Oncology, Nutrition and Dietetics and Pharmacology, having authored 27 papers that have together received 2.8k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (6 papers), Muscle Physiology and Disorders (3 papers), Peptidase Inhibition and Analysis (3 papers), Nutrition and Health in Aging (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Immune Response and Inflammation (3 papers), Nanoplatforms for cancer theranostics (2 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Hematology (394 citations), Oncology (729 citations), Cancer Research (381 citations), Molecular Biology (1.5k citations) and Immunology (399 citations). Douglas D. Lazarus has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Peter J. Elliott, Antonia T. Destree, Vito J. Palombella, Julian Adams, J I Johnson, Christine S. Pien, Jochen Maas, Edward A. Sausville, Lyle L. Moldawer and Stephen F. Lowry. Their work appears in journals such as Proceedings of the National Academy of Sciences, Domestic Animal Endocrinology, The Journal of Immunology, Breast Cancer Research and Treatment and American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact